RecallDepth
Class III Terminated

Apri (desogestrel and ethinyl estradiol tablets USP), 0.15 mg/0.03 mg, 6 Cyclic dispensers X 28 tablets, Rx only, Teva Pharmaceuticals, Sellersville, PA. NDC 0555-9043-58

Company
Teva Pharmaceuticals Usa
Recall Initiated
June 17, 2014
Posted
July 23, 2014
Recall Number
D-1436-2014
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
1104 blister packs
Firm Location
North Wales, PA, United States

Reason for Recall

Failed Impurities/Degradation Specifications: out of specification impurity test results.

Distribution

Nationwide

Lot / Code Info

Lot 3805324A Exp. 11/14

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class III Drug recalls